Tuesday, 14 August 2012

Breast Cancer Treatment-European Regulators-Mtor Inhibitors-Novartis

Novartis drug Afinitor gets EU nod for breast cancer
Health Benefits Of Carrot Juice-Cancer Prevention-Beta Carotene-Breast Cancer
A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel

ZURICH (Reuters) - Novartis drug Afinitor, expected to become a major seller for the Swiss drugmaker, was approved by European regulators to treat women with a certain type of breast cancer, the company said on Monday. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. American health regulators also backed the drug as a breast cancer treatment. ... read more..

No comments:

Post a Comment